You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

361 Results
Recognizing the challenge and opportunity of take-home cancer medications, Cancer Care Ontario hosted a policy planning and consultation session in...
Reconnaissant le défi et la possibilité des médicaments contre le cancer à prendre à la maison, Action Cancer Ontario a organisé une séance de...
Regimen
Cancer Type:
Genitourinary, 
Prostate
Intent: Curative, Palliative
Funding:
ODB - General Benefit
    relugolix
May 2025
Drug
Other Name(s): Orgovyx®
May 2025
Drug
Other Name(s): Lupron® , Lupron Depot® , Eligard®
May 2025
Regimen
Cancer Type:
Genitourinary, 
Prostate
Intent: Neoadjuvant, Adjuvant, Palliative
Funding:
ODB - General Benefit
    leuprolide - long-acting formulation
May 2025

Pages